Penumbra (PEN) Receivables (2014 - 2026)
Penumbra's (PEN) quarterly Receivables came in at $183.3 million in Q1 2026, up 9.12% year-on-year from $168.0 million in Q1 2025, and down 3.54% on a QoQ basis from $190.0 million in Q4 2025.
Penumbra (PEN) Receivables (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Receivables data on file, last reported at $183.3 million in Q1 2026.
- On a quarterly basis, Receivables rose 9.12% year-over-year to $183.3 million in Q1 2026; TTM through Mar 2026 was $183.3 million, a 9.12% increase from a year earlier, with the FY2025 full-year figure at $190.0 million, up 13.33% from the prior year.
- Receivables for Q1 2026 stood at $183.3 million, down from $190.0 million in the prior quarter.
- Over the last five years, Receivables for PEN reached as high as $209.0 million in Q2 2023 and fell as low as $143.4 million in Q1 2022.
- Historically, Receivables has averaged $187.3 million across 5 years, with a median of $189.0 million in 2022.
- Across the five-year window, Receivables jumped 57.41% in 2022 and declined 16.9% in 2024, its largest moves.
- Year by year, Receivables stood at $203.4 million in 2022, then declined by 0.79% to $201.8 million in 2023, then retreated by 16.9% to $167.7 million in 2024, then advanced by 13.33% to $190.0 million in 2025, then slipped by 3.54% to $183.3 million in 2026.
- Per Business Quant data, the three most recent Receivables figures were $183.3 million in Q1 2026, $190.0 million in Q4 2025, and $183.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 183.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183.30 Mn |
| Dec 31, 2025 | 190.02 Mn |
| Sep 30, 2025 | 183.43 Mn |
| Jun 30, 2025 | 175.54 Mn |
| Mar 31, 2025 | 167.98 Mn |
| Dec 31, 2024 | 167.67 Mn |
| Sep 30, 2024 | 176.05 Mn |
| Jun 30, 2024 | 200.83 Mn |
| Mar 31, 2024 | 191.99 Mn |
| Dec 31, 2023 | 201.77 Mn |
| Sep 30, 2023 | 206.62 Mn |
| Jun 30, 2023 | 208.97 Mn |
| Mar 31, 2023 | 207.36 Mn |
| Dec 31, 2022 | 203.38 Mn |
| Sep 30, 2022 | 189.01 Mn |
| Jun 30, 2022 | 187.39 Mn |
| Mar 31, 2022 | 143.42 Mn |
| Dec 31, 2021 | 133.94 Mn |
| Sep 30, 2021 | 120.07 Mn |
| Mar 31, 2021 | 126.42 Mn |